Literature DB >> 18486167

Haptoglobin, inflammation and disease.

Isaac K Quaye1.   

Abstract

Haptoglobin is an acute phase protein that scavenges haemoglobin in the event of intravascular or extravascular haemolysis. The protein exists in humans as three main phenotypes, Hp1-1, Hp2-2 and Hp2-1. Accumulated data on the protein's function has established its strong association with diseases that have inflammatory causes. These include parasitic (malaria), infectious (HIV, tuberculosis) and non-infectious diseases (diabetes, cardiovascular disease and obesity) among others. Phenotype-dependent poor disease outcomes have been linked with the Hp2-2 phenotype. The present review brings this association into perspective by looking at the functions of the protein and how defects in these functions associated with the Hp2 allele affect disease outcome. A model is provided to explain the mechanism, which appears to be largely immunomodulatory.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18486167     DOI: 10.1016/j.trstmh.2008.04.010

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  132 in total

1.  Proteomic screening of glycoproteins in human plasma for frailty biomarkers.

Authors:  Kinza S Shamsi; Anson Pierce; Aaron S Ashton; Dipti G Halade; Arlan Richardson; Sara E Espinoza
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2012-01-04       Impact factor: 6.053

2.  Development of a serum profile for healthy aging.

Authors:  Lauri O Byerley; Larry Leamy; Sun W Tam; Chau-Wen Chou; Eric Ravussin
Journal:  Age (Dordr)       Date:  2010-05-19

Review 3.  Body fluid biomarkers for multiple sclerosis--the long road to clinical application.

Authors:  Charlotte E Teunissen; Arjan Malekzadeh; Cyra Leurs; Claire Bridel; Joep Killestein
Journal:  Nat Rev Neurol       Date:  2015-09-22       Impact factor: 42.937

4.  Exogenous glucocorticoids amplify the costs of infection by reducing resistance and tolerance, but effects are mitigated by co-infection.

Authors:  Laura A Schoenle; Ignacio T Moore; Alana M Dudek; Ellen B Garcia; Morgan Mays; Mark F Haussmann; Daniela Cimini; Frances Bonier
Journal:  Proc Biol Sci       Date:  2019-04-10       Impact factor: 5.349

5.  Identification of haptoglobin and apolipoprotein A-I as biomarkers for high altitude pulmonary edema.

Authors:  Yasmin Ahmad; Dhananjay Shukla; Iti Garg; Narendra K Sharma; Saurabh Saxena; V K Malhotra; Kalpana Bhargava
Journal:  Funct Integr Genomics       Date:  2011-07-14       Impact factor: 3.410

6.  Acute-phase protein α1-antitrypsin inhibits neutrophil calpain I and induces random migration.

Authors:  Mariam Al-Omari; Elena Korenbaum; Matthias Ballmaier; Ulrich Lehmann; Danny Jonigk; Dietmar J Manstein; Tobias Welte; Ravi Mahadeva; Sabina Janciauskiene
Journal:  Mol Med       Date:  2011-04-11       Impact factor: 6.354

7.  Early-life immune activation increases song complexity and alters phenotypic associations between sexual ornaments.

Authors:  Loren Merrill; Madeleine F Naylor; Merria Dalimonte; Sean McLaughlin; Tara E Stewart; Jennifer L Grindstaff
Journal:  Funct Ecol       Date:  2017-06-29       Impact factor: 5.608

8.  The Equine PeptideAtlas: a resource for developing proteomics-based veterinary research.

Authors:  Louise Bundgaard; Stine Jacobsen; Mette A Sørensen; Zhi Sun; Eric W Deutsch; Robert L Moritz; Emøke Bendixen
Journal:  Proteomics       Date:  2014-02-16       Impact factor: 3.984

9.  Shenfu Injection suppresses inflammation by targeting haptoglobin and pentraxin 3 in rats with chronic ischemic heart failure.

Authors:  Si-Dao Zheng; Hong-Jin Wu; Shao-Ping Yu; Jian-Xun Ren; Wei-Wei Duo; Zeng-Chun Ma; Yue Gao; Sheng-Qi Wang; Yu-Na Liu
Journal:  Chin J Integr Med       Date:  2013-03-15       Impact factor: 1.978

10.  Mechanisms regulating repression of haptoglobin production by peroxisome proliferator-activated receptor-gamma ligands in adipocytes.

Authors:  Cecile Vernochet; Kathryn E Davis; Philipp E Scherer; Stephen R Farmer
Journal:  Endocrinology       Date:  2009-12-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.